Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

9.78

+0.05 (0.51%)

At close: Jul 29, 2026, 4:00 PM EDT

9.70

-0.08 (-0.87%)

After-hours: Jul 29, 2026, 5:46 PM EDT

Zevra Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	122.29	106.47	23.61	27.46	10.46	28.65
Revenue Growth	201.29%	350.92%	-14.02%	162.58%	-63.50%	115.61%
Gross Profit	105.26	89.99	16.2	25.29	10.12	26.59
Operating Income	4.14	-62.94	-87	-49.6	-42.51	7.73
Net Income	74.16	83.23	-105.51	-46.05	-41.54	-62.9
Earnings Per Share	1.99	1.35	-2.28	-1.30	-0.78	-2.11
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	200.62	191.01	69.5	67.74	82.85	112.35
Total Debt	1.15	63.21	60.3	43.77	14.12	1.59
Net Cash (Debt)	199.47	127.81	9.2	23.97	68.72	110.76
Net Cash Growth	25022.04%	1289.18%	-61.62%	-65.12%	-37.95%	-
Net Cash Per Share	3.45	2.23	0.20	0.68	1.99	3.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	12.77	-1.6	-69.67	-33.54	-18.72	10.44
Capital Expenditures	-0.77	-0.84	-	-0.3	-0.09	-0.1
Free Cash Flow	12	-2.43	-69.67	-33.83	-18.81	10.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	86.07%	84.52%	68.59%	92.09%	96.72%	92.81%
Operating Margin	3.39%	-59.12%	-368.47%	-180.63%	-406.44%	26.98%
Pretax Margin	62.09%	81.41%	-381.76%	-167.69%	-404.75%	-29.74%
Profit Margin	60.65%	78.17%	-446.85%	-167.69%	-397.24%	-29.86%
FCF Margin	9.81%	-2.29%	-295.04%	-123.20%	-179.86%	36.08%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	4.93	6.64	-	-	-	-
Forward PE	17.19	19.15	102.50	102.50	102.50	24.17
P/FCF Ratio	47.11	-	-	-	-	29.50
PS Ratio	4.62	4.78	18.96	9.91	15.16	10.64